- Home
- CRBP vs PPIH Comparison
CRBP vs PPIH Comparison
Compare CRBP & PPIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- PPIH
- Stock Information
- Founded
- CRBP 2009
- PPIH 1993
- Country
- CRBP United States
- PPIH United States
- Employees
- CRBP N/A
- PPIH N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- PPIH Pollution Control Equipment
- Sector
- CRBP Health Care
- PPIH Industrials
- Exchange
- CRBP Nasdaq
- PPIH Nasdaq
- Market Cap
- CRBP 233.5M
- PPIH 253.5M
- IPO Year
- CRBP N/A
- PPIH N/A
- Fundamental
- Price
- CRBP $11.25
- PPIH $27.61
- Analyst Decision
- CRBP Strong Buy
- PPIH
- Analyst Count
- CRBP 9
- PPIH 0
- Target Price
- CRBP $49.00
- PPIH N/A
- AVG Volume (30 Days)
- CRBP 561.9K
- PPIH 107.8K
- Earning Date
- CRBP 11-07-2025
- PPIH 12-22-2025
- Dividend Yield
- CRBP N/A
- PPIH N/A
- EPS Growth
- CRBP N/A
- PPIH N/A
- EPS
- CRBP N/A
- PPIH 1.25
- Revenue
- CRBP N/A
- PPIH $181,198,000.00
- Revenue This Year
- CRBP N/A
- PPIH $25.58
- Revenue Next Year
- CRBP $220.00
- PPIH $8.72
- P/E Ratio
- CRBP N/A
- PPIH $22.32
- Revenue Growth
- CRBP N/A
- PPIH 14.90
- 52 Week Low
- CRBP $4.64
- PPIH $8.81
- 52 Week High
- CRBP $20.77
- PPIH $33.09
- Technical
- Relative Strength Index (RSI)
- CRBP 32.54
- PPIH 55.55
- Support Level
- CRBP $11.59
- PPIH $26.27
- Resistance Level
- CRBP $18.11
- PPIH $29.94
- Average True Range (ATR)
- CRBP 1.69
- PPIH 1.74
- MACD
- CRBP -0.95
- PPIH 0.07
- Stochastic Oscillator
- CRBP 0.21
- PPIH 57.99
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About PPIH Perma-Pipe International Holdings Inc.
Perma-Pipe International Holdings Inc is engaged in the manufacture and sale of products in the reportable segment of Piping Systems. The company engineers, designs, manufactures, and sells specialty piping systems and leak detection systems. Specialty piping systems include insulated and jacketed district heating and cooling piping systems for efficient energy distribution from central energy plants to multiple locations, primary and secondary containment piping systems for transporting chemicals, hazardous fluids, and petroleum products, and the coating and insulation of oil and gas gathering and transmission pipelines. It operates in the United States, Canada, the Middle East, Europe, India, and other countries.